Isaac Scientific Publishing

Journal of Advances in Molecular Biology

Oxidative Stress in Liver of Streptozotocin Induced Diabetic Rats: Ameliorating Role of Aegle Marmelos Leaf Extract

Download PDF (394.9 KB) PP. 72 - 79 Pub. Date: June 8, 2017

DOI: 10.22606/jamb.2017.11005


  • Manju T
    Molecular Neurobiology and Cell Biology Unit, Centre for Neuroscience, Department of Biotechnology, Cochin University of Science and Technology, Cochin-682022, Kerala, India
  • Anju T R*
    Molecular Neurobiology and Cell Biology Unit, Centre for Neuroscience, Department of Biotechnology, Cochin University of Science and Technology, Cochin-682022, Kerala, India


Hepatic tissue damage mediated through altered antioxidant defence is one of the characteristic features of diabetes. Phytotherapy using Aegle marmelos leaf extract has been reported to control diabetes complications on brain functions. The present study was carried out to evaluate whether the anti-hypergycemic effects of Aegle marmelos leaf extract can regulate diabetes related hepatic oxidative stress. To understand this, antioxidant and peroxide levels and expression of stress related Hypoxia inducible factor 1 (HIF 1) mRNA were analysed in liver tissue of experimental rat models. The decreased total antioxidant level with elevated peroxide level along with upregulation of HIF 1 gene expression indicates poor oxidative defenses in the liver of diabetic rats. These altered parameters were reversed to near control level by Aegle marmelos treatment which indicates that Aegle marmelos can not only regulate blood glucose levels but also control diabetes related hepatic complications.


Reactive oxygen species; antioxidants; free radicals; hyperglycemia; HIF-1α


[1] B. Jayakar and B. Suresh, “Anti hyperglycemic and hypoglycemic effect of Aporosalindleyana in alloxan-induced diabetic rats,” Journal of Ethnopharmacology, vol. 84, pp. 247-249, 2003.

[2] J. L. Evans, I. D. Goldfine, B. A. Maddax, and G. M. Grodsky, “Are oxidative stress –activated signaling pathway mediators of insulin resistance and beta cell dysfunction?,” Diabetes vol. 52, pp. 1-8, 2003.

[3] J. L. Evans, I. D. Goldfine, B. A. Maddux, and G. M. Grodsky, “Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes,” Endocr Rev, vol. 23, pp. 599–622, 2002.

[4] R. L. Wilson. “Free radicals and tissue damage, mechanistic evidence from radiation studies,” in Biochemical mechanisms of Liver Injury. New York, Academic Press, pp. 123–125, 1998.

[5] R. Harini and K. V. Pugalendi, “Antioxidant and anti hyperlipidaemic activity of protocatechuic acid on Streptozotocin-diabetic rats research gate,” Redox Rep., vol. 15, pp. 71-80, 2010.

[6] D. Jay, H. Hitomi, and K. K. Griendling, “Oxidative stress and diabetic cardiovascular complications,” Free Rad Biol Med, vol. 40, pp. 183–92, 2006.

[7] E. Wright, J. L. Scism-Bacon, and L. C. Glass, “Oxidative stress in type 2 diabetes: the role of fasting and postprandial glycemia,” Int J ClinPrac, vol. 60, pp. 308–14, 2006.

[8] G. L. King, and M. R. Loken, “Hyperglycemia-induced oxidative stress in diabetic complications,” Histochem Cell Biol, vol. 122, pp. 333–338, 2004.

[9] J. W. Boynes. “Role of oxidative stress in development of complication in diabetes,” Diabetes, vol. 40, pp. 405–411, 1991.

[10] A. P. Zou, and A. W. Cowley Jr, “Reactive oxygen species and molecular regulation of renal oxygenation,” Acta Physiol Scand, vol. 179, pp. 233-241, 2003.

[11] J. J. Bullock, S. L. Mehta, Y. Lin, P. Lolla, and P. A. Li, “Hyperglycemia-enhanced ischemic brain damage in mutant manganese SOD mice is associated with suppression of HIF-1alpha,” Neurosci Lett, vol. 456, pp. 89-92, 2009.

[12] R. Marfella, M. D'Amico, C. Di Filippo, E. Piegari, F. Nappo, K. Esposito et al, “Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1,”Diabetologia, vol. 45, pp. 1172-1181, 2002.

[13] G. Papaccio, F. A. Pisanti, M. V. Latronico, E. Ammendola, and M. Galdieri, “Multiple low-dose and single high-dose treatments with streptozotocin do not generate nitric oxide,” J Cell Biochem, vol. 77, pp. 82–91, 2000.

[14] V. Sanchez-Valle, N. C. Chavez-Tapia, M. Uribe, and N. Mendez-Sanchez, “Role of oxidative stress and molecular changes in liver fibrosis: A review,” Curr. Med. Chem, vol. 19, pp. 4850–4860, 2012.

[15] M. C. Sabu, and R. Kuttan, “Antidiabetic activity of Aeglemarmelos and its relationship with its antioxidant properties,” Indian J Physiol Pharmacol, vol. 48, no. 1, pp. 81-88, 2004.

[16] P. T. C. Ponnachan, C. S. Paulose, and K. R. Panikkar, “Effect of leaf extract of Aegle marmelos in diabetic rats,” Indian Journal of Experimental Biology, vol. 31, pp. 345–347, 1993.

[17] J. K. Grover, S. Yadav, and V. Vats, “Medicinal plants of India with anti-diabetic potential,” J Ethanopharmacol, vol. 81, pp. 81-100, 2002.

[18] A. V. Das, P. S. Padayatti, and C. S. Paulose, “Effect of leaf extract of Aeglemarmelos (L.) Correa ex Roxb on histological and ultra structural changes in tissues of Streptozotocin induced diabetic rats,” Indian Journal of Experimental Biology, vol. 34, pp. 341-345, 1996.

[19] O. H. Lowry, N. J. Roserbrough, A. L. Farr, and R. J. Randall, “Protein measurements and folin phenol reagent,” J Biol Chem, vol. 193, pp. 265-275, 1951.

[20] A. Junod, A. E. Lambert, W. Staufferacher, and A. E. Renold, “Diabetogenic action of Streptozotocin: Relationship of dose to metabolic response,” J. Clin. Invest, vol. 48, pp. 2129-2139, 1969.

[21] M. Salahuddin and S. S. Jalalpure, “Anti diabetic activity of aqueous fruit extract of CucumistrigonusRoxb. in Streptozotocin- induced-diabetic rats,” J Ethno pharmacol, vol. 127, no. 2, pp. 565-567, 2010.

[22] R. Anandharajan, S. Jaiganesh, N. Shankernarayanan, R. Viswakarma, and A. Balakrishnan, “In vitro glucose uptake activity of Aegle marmelose and Syzygiumcumini by activation of Glut-4, PI3 kinase and PPARγ in L 6 myotubes,” Phytomedicine, vol. 13, pp. 434-441, 2006.

[23] M. W. Girotti, “Mechanisms of lipid peroxidation,” Free RadicBiolMed, vol. 1, pp. 87–95, 1985.

[24] C. W. Karpen, K. A. Pritchard, A. J. Merola Jr., and R. V. Panganamala, “Alterations of the prostaglandin thromboxane ratio in streptozotocin induced diabetic rats,” ProstaglandLeukotrienMed, vol. 8, pp. 93–103, 1982.

[25] F. Giacco, and M. Brownlee, “Oxidative Stress and Diabetic Complications,” Circ Res, vol. 107, no. 9, pp. 1058-70, 2010.

[26] S. B. Catrina, K. Okamoto, T. Pereira, K. Brismar, and L. Poellinger, “Hyperglycemia Regulates HypoxiaInducible Factor-1α Protein Stability and Function,” Diabetes, vol. 53, pp. 3226–3232, 2004.

[27] T. R. Anju, and C. S. Paulose, “Amelioration of hypoxia-induced striatal 5-HT(2A) receptor, 5-HT transporter and HIF1 alterations by glucose, oxygen and epinephrine in neonatal rats,” Neuroscience letters, vol. 502, no. 3, pp. 129-132, 2011.